๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thymic Malignancies

Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors NCT06301945n/a1 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Artificial Intelligence Diagnostics, Recurrence Prediction Tool A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest NCT05354570Phase 27 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Intensity-Modulated Pleural Radiation Therapy (IMPRINT) PT-112 in Subjects With Thymoma and Thymic Carcinoma NCT05104736Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: PT-112 Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites๐Ÿ“ Iowa City๐Ÿ“ Boston๐Ÿ“ Royal Oak Novartis Pharmaceuticals ยท Tests: 225Ac-ETN029, 111In-ETN029 Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma NCT07598955Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: Cyclophosphamide, Fludarabine, EB-CAR30-NK, EB-CAR5-NK, EB-CARMSLN-NK A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors NCT06248515Phase 24 sites๐Ÿ“ Palo Alto๐Ÿ“ Washington D.C.๐Ÿ“ Chicago Georgetown University ยท Tests: Sacituzumab govitecan-hziy Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ Chicago๐Ÿ“ New York AIDS Malignancy Consortium ยท Tests: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors NCT07429851n/a1 site๐Ÿ“ Milan European Institute of Oncology Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) NCT06402708Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: Chemotherapy, Radiotherapy Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma NCT06885697Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: cyclophosphamide, fludarabine, TNhYP218 CAR T Cells, mesothelin expression testing Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors NCT02146170n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) NCT06141369NA1 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: individualized mRNA neoantigen vaccine (mRNA-0523-L001) First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) NCT05832827Phase 21 site๐Ÿ“ Chลซล National Cancer Center, Japan ยท Tests: MK-3475, Lenvatinib, Carboplatin, Paclitaxel Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer NCT03295227Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Pembrolizumab The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor NCT06311968Phase 21 site๐Ÿ“ Shanghai Jian Chen ยท Tests: Proton radiotherapy, combined platinum based chemotherapy Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor NCT06311955Phase 21 site๐Ÿ“ Shanghai Jian Chen ยท Tests: Carbon ion radiotherapy, combined with platinum-based regimen Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) NCT05558644NA3 sites๐Ÿ“ Paris๐Ÿ“ Paris๐Ÿ“ Suresnes Institut Curie ยท Tests: single arm for all patients Molecular Analysis and Treatment Options of Thymic Malignancies NCT05667948n/a1 site๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: Chemotherapy Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma NCT05633615Phase 295 sites๐Ÿ“ Tucson๐Ÿ“ Tucson๐Ÿ“ Fayetteville SWOG Cancer Research Network ยท Tests: Axicabtagene Ciloleucel, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Hypofractionated Radiotherapy for Thymic Epithelial Tumors NCT06692062NA1 site๐Ÿ“ Changsha Rongrong Zhou ยท Tests: Hypofractionated Radiation Therapy Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma NCT05672251Phase 21 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Loncastuximab Tesirine, Mosunetuzumab Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer NCT04522687n/a1 site๐Ÿ“ Shanghai Shanghai Cancer Hospital, China An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors NCT07691619Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Postoperative hypo-fractionated radiotherapy Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors NCT06186726Phase 21 site๐Ÿ“ Shanghai Jian Chen ยท Tests: carbon ion radiotherapy Establishing Prospective Mediastinal Tumor Database of PUMCH NCT06421805n/a1 site๐Ÿ“ Beijing Peking Union Medical College Hospital Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma NCT07324629Phase 21 site๐Ÿ“ Shanghai Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ยท Tests: Sacituzumab tirumotecan Neoadjuvant Treatment For Locally Advanced Thymic Cancer NCT06019468Phase 21 site๐Ÿ“ Shanghai Shanghai Pulmonary Hospital, Shanghai, China ยท Tests: Envolizumab combined with radiotherapy Ivonescimab for the Treatment of Thymic Cancer NCT06980077Phase 25 sites๐Ÿ“ Davis๐Ÿ“ Irvine๐Ÿ“ Los Angeles Jonsson Comprehensive Cancer Center ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ivonescimab, Magnetic Resonance Imaging A Study of KC1036 in Patients with Advanced Thymic Tumors NCT05683886Phase 22 sites๐Ÿ“ Shanghai๐Ÿ“ Chengdu Beijing Konruns Pharmaceutical Co., Ltd. ยท Tests: KC1036
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy